Literature DB >> 6301966

Nervous and ocular disorders in children with cholestasis and vitamin A and E deficiencies.

F Alvarez, P Landrieu, P Laget, F Lemonnier, M Odièvre, D Alagille.   

Abstract

Thirteen children, aged 10 months to 20 years, presenting with chronic cholestasis from the first month of life and with low serum levels of vitamins A and/or E, have been investigated for neurological and ophthalmological symptoms. Clinical findings consisted of 4 types: peripheral neuropathy; cerebellar dysfunction; abnormalities of eye movement, and retinal degenerative changes. The results of electrophysiological and morphological studies of muscle and nerves were consistent with neurono-axonal degeneration. Electrical abnormalities of the retina, especially a decrease of the b wave of electroretinogram, appear to be the first sign of the syndrome, allowing early detection. Evidence for vitamin deficiency (E or E+A) suggests substitutive parenteral treatment in such patients.

Entities:  

Mesh:

Year:  1983        PMID: 6301966     DOI: 10.1002/hep.1840030321

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  10 in total

Review 1.  Nutrition and growth in patients with chronic liver disease.

Authors:  D A Kelly
Journal:  Indian J Pediatr       Date:  1995 Sep-Oct       Impact factor: 1.967

Review 2.  Alagille syndrome.

Authors:  Michelle Hadchouel
Journal:  Indian J Pediatr       Date:  2002-09       Impact factor: 1.967

3.  Vitamin E prevents changes in the cornea and conjunctiva due to vitamin A deficiency.

Authors:  Azusa Fujikawa; Huaqing Gong; Tsugio Amemiya
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-03-15       Impact factor: 3.117

Review 4.  Molecular Mechanisms Underlying the Therapeutic Role of Vitamin E in Age-Related Macular Degeneration.

Authors:  Genea Edwards; Caroline G Olson; Carlyn P Euritt; Peter Koulen
Journal:  Front Neurosci       Date:  2022-05-04       Impact factor: 5.152

5.  Intermittent horizontal saccade failure ('ocular motor apraxia') in children.

Authors:  C M Harris; F Shawkat; I Russell-Eggitt; J Wilson; D Taylor
Journal:  Br J Ophthalmol       Date:  1996-02       Impact factor: 4.638

Review 6.  Vitamin E--its role in neurological function.

Authors:  D P Muller
Journal:  Postgrad Med J       Date:  1986-02       Impact factor: 2.401

7.  Oral vitamin E supplements can prevent the retinopathy of abetalipoproteinaemia.

Authors:  P Runge; D P Muller; J McAllister; D Calver; J K Lloyd; D Taylor
Journal:  Br J Ophthalmol       Date:  1986-03       Impact factor: 4.638

8.  Effect of abnormal liver function on vitamin E status and supplementation in adults with cystic fibrosis.

Authors:  R J Stead; D P Muller; S Matthews; M E Hodson; J C Batten
Journal:  Gut       Date:  1986-06       Impact factor: 23.059

Review 9.  The role of vitamin E in the treatment of the neurological features of abetalipoproteinaemia and other disorders of fat absorption.

Authors:  D P Muller; J K Lloyd; O H Wolff
Journal:  J Inherit Metab Dis       Date:  1985       Impact factor: 4.982

10.  A study of the relationship between neurological function and serum vitamin E concentrations in patients with cystic fibrosis.

Authors:  H J Willison; D P Muller; S Matthews; S Jones; A Kriss; R J Stead; M E Hodson; A E Harding
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-11       Impact factor: 10.154

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.